However, a subset of patients exhibited persistent or even increased TSPO binding, indicating ongoing or exacerbated inflammation that corresponded to the cognitive and neurological deficits experienced by stroke patients and thus poorer functional outcomes. This evidence concerns the gene TSPO and stroke disorder.